Guardant Health: Shield Colorectal Cancer Screening To Sustain Growth [Seeking Alpha]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
GH's Shield test addresses major barriers to screening, expanding access to 50 million Americans and driving a 335% YoY increase in screening volumes. Revenue growth remains robust, with FY2025 revenue at $981 million (+33% YoY) and Q4 preliminary revenue of $280 million (+39% YoY), outpacing peers. Key risks include adoption lag and reimbursement uncertainty, but Shield's FDA approval and Medicare coverage position GH for sustained long-term growth. Tom Werner/DigitalVision via Getty Images Introduction and Investment Thesis I am bullish on Guardant Health, Inc. ( GH ), driven by a collaboration with Quest Diagnostics ( DGX ), which will broaden access to Shield colorectal cancer screening. Under this collaboration, Guardant has access to over 650,000 This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, o
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart PlatformBusiness Wire
- Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]Yahoo! Finance
- Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 ResultsBusiness Wire
- How Recent Analyst Targets Are Shaping The Evolving Story For Guardant Health (GH) [Yahoo! Finance]Yahoo! Finance
- Guggenheim Analyst is Bullish on Guardant Health, Inc. (GH) [Yahoo! Finance]Yahoo! Finance
GH
Earnings
- 10/29/25 - Beat
GH
Sec Filings
- 1/16/26 - Form 4
- 1/16/26 - Form 4
- 1/12/26 - Form 8-K
- GH's page on the SEC website